Orion Oyj ORNBV

HEL: ORNBV | ISIN: FI0009014377 12/09/2025

68,15 EUR (+0,22%)

(+0,22%) 12/09/2025

Grafiek Orion Oyj

Grafiek Orion Oyj

1 dag1d 0,22%
1 week1w 3,89%
1 maand1m -1,52%
3 maanden3m 7,75%
6 maanden6m 20,32%
1 jaar1j 44,72%
5 jaar5j 75,28%

dinsdag 28 oktober 2025, 10:00

Kwartaalcijfers (3de kwartaal)

Orion Oyj in het nieuws

Toon enkel gratis nieuws

20 augustus 2025 · 337,000 Orion Corporation A shares converted into B shares · Persbericht

8 augustus 2025 · Orion Corporation: Managers’ transactions – Juhani Kankaanpää · Persbericht

4 augustus 2025 · Orion Corporation: Managers’ transactions – Satu Ahomäki · Persbericht

21 juli 2025 · Darolutamide receives EU approval in third indication for patients with advanced prostate cancer · Persbericht

18 juli 2025 · Orion Group Half-Year Financial Report January–June 2025 · Persbericht

18 juli 2025 · Orion Corporation’s financial reporting and Annual General Meeting in 2026 · Persbericht

9 juli 2025 · Inside information: Orion upgrades full-year outlook for 2025 · Persbericht

4 juli 2025 · Orion publishes Half-Year Financial Report for January–June 2025 and holds a webcast on 18 July 2025 · Persbericht

23 juni 2025 · 141,959 Orion Corporation A shares converted into B shares · Persbericht

20 juni 2025 · CHMP recommends third indication for darolutamide for patients with advanced prostate cancer · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe